Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double Blind, Randomized, Placebo-Controlled, Proof of Concept, Dose Finding Study of Intraarticular Bone Morphogenetic Protein (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

NCT01111045 is registered in ClinicalTrials.gov with Stryker Biotech as lead sponsor.

NCT NCT01111045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01111045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double Blind, Randomized, Placebo-Controlled, Proof of Concept, Dose Finding Study of Intraarticular Bone Morphogenetic Protein (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
Lead sponsor
Stryker Biotech
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
August 31, 2011
Enrollment
355 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee